收稿日期: 2026-01-19
网络出版日期: 2026-04-29
基金资助
教育部产学合作协同育人项目(230800179253843);广州市市校（院）企联合资助专题项目(2023A03J0401)
Interpretation of the 2025 Society for Vascular Surgery Clinical Practice Guideline Update for Intermittent Claudication
Received date: 2026-01-19
Online published: 2026-04-29
2025年美国血管外科学会（SVS）在《Journal of Vascular Surgery》上发布了其对2015版间歇性跛行（IC）管理指南的首次重点更新。更新指南围绕六大PICO问题提出12条推荐，其中包括2项最佳实践声明，更新指南首次将低剂量利伐沙班纳入IC管理路径，强化了运动及药物治疗的一线策略地位，并对血运重建的适用情形、胫动脉介入治疗以及药物涂层器械的应用提出了更为慎重的意见。本文依据最新的指南原文，对其核心更新进行系统阐释，着重剖析各项建议的推荐强度与证据等级，从而为血管外科医师构建一个实用的临床决策参考框架。
曹华燕 , 陈松伟 , 李强 . 2025年美国血管外科学会《间歇性跛行临床实践指南（更新版）》解读[J]. 实用医学杂志, 2026 , 42(9) : 1485 -1490 . DOI: 10.3969/j.issn.1006-5725.2026.09.001
In 2025， the American Society of Vascular Surgery （SVS） released its first focused update on the 2015 management guidelines for intermittent claudication （IC） in the Journal of Vascular Surgery. This updated guideline set is structured around six key PICO questions， leading to twelve evidence-based recommendations， including two best-practice statements. Significantly， this update is notable because it represents the first incorporation of low-dose rivaroxaban into the management pathway for IC， highlighting the significance of both exercise therapy and pharmacologic treatment as primary strategies. Moreover， the guidelines take a more prudent approach towards indications for revascularization， tibial artery interventions， and the use of drug-coated devices. This article systematically interprets the core updates from the latest guideline text， concentrating on analyzing the strength of the recommendations and the level of evidence backing each suggestion. The objective is to establish a practical framework for clinical decision-making to aid vascular surgeons in their clinical practice.
| [1] | CONTE M S， AULIVOLA B， BARSHES N R， et al. Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication： Focused update［J］. J Vasc Surg， 2025， 82（2）： 303-326.e11. doi：10.1016/j.jvs.2025.04.041 . |
| [2] | FOWKES F G R， RUDAN D， RUDAN I， et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010： A systematic review and analysis［J］. Lancet， 2013， 382（9901）： 1329-1340. doi：10.1016/S0140-6736（13）61249-0 . |
| [3] | FROUD J L J， LANDIN M， WAFI A， et al. Rate and predictors of disease progression in patients with conservatively managed intermittent claudication： A systematic review［J］. Ann Vasc Surg， 2025， 112： 183-192. doi：10.1016/j.avsg.2024.12.009 . |
| [4] | TAN L T， MCDERMOTT K M， HICKS C W. Overview and comparison of contemporary Society for Vascular Surgery， American Heart Association/American College of Cardiology， and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication［J］. Semin Vasc Surg， 2024， 37（2）： 188-209. doi：10.1053/j.semvascsurg.2024.04.006 . |
| [5] | NORDANSTIG J， BEHRENDT C A， BAUMGARTNER I， et al. Editor’s choice —European society for vascular surgery （ESVS） 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication［J］. Eur J Vasc Endovasc Surg， 2024， 67（1）： 9-96. doi：10.1016/j.ejvs.2023.08.067 . |
| [6] | JAROSINSKI M C， HAFEEZ M S， SRIDHARAN N D， et al. Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication［J］. J Vasc Surg， 2025， 81（1）： 200-209.e3. doi：10.1016/j.jvs.2024.08.033 . |
| [7] | LAMPRIDOU S， DOMUN T， ROSENBERG J， et al. Multicomponent interventions designed to support adherence to guideline-recommended therapy in patients with peripheral artery disease： A scoping review［J］. Vasc Med， 2025， 30（3）： 343-352. doi：10.1177/1358863X251315071 . |
| [8] | SHI R， BULATAO N， TANIOUS A. Novel interventions to improve adherence to guideline-directed medical therapy in claudicants［J］. J Clin Med， 2025， 14（15）： 5309. doi：10.3390/jcm14155309 . |
| [9] | NORGREN L， HIATT W R， DORMANDY J A， et al. Inter-society consensus for the management of peripheral arterial disease （TASC II）［J］. J Vasc Surg， 2007， 45（）： S5-S67. doi：10.1016/j.jvs.2006.12.037 . |
| [10] | CONTE M S， POMPOSELLI F B， CLAIR D G， et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities： Management of asymptomatic disease and claudication［J］. J Vasc Surg， 2015， 61（3 ）： 2S-41S. doi：10.1016/j.jvs.2014.12.009 . |
| [11] | ANDERSON J L， HALPERIN J L， ALBERT N M， et al. Management of patients with peripheral artery disease （compilation of 2005 and 2011 ACCF/AHA guideline recommendations）： A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines［J］. Circulation， 2013， 127（13）： 1425-1443. doi：10.1161/CIR.0b013e31828b82aa . |
| [12] | BURGESS L， BABBER A， SHALHOUB J， et al. Neuromuscular Electrical Stimulation for Intermittent Claudication （NESIC）： Multicentre， randomized controlled trial［J］. Br J Surg， 2023， 110（12）： 1785-1792. doi：10.1093/bjs/znad299 . |
| [13] | MCDERMOTT M M， DOMANCHUK K， LIU K， et al. The Group Oriented Arterial Leg Study （GOALS） to improve walking performance in patients with peripheral arterial disease［J］. Contemp Clin Trials， 2012， 33（6）： 1311-1320. doi：10.1016/j.cct.2012.08.001 . |
| [14] | HARWOOD A E， PYMER S， INGLE L， et al. Exercise training for intermittent claudication： A narrative review and summary of guidelines for practitioners［J］. BMJ Open Sport Exerc Med， 2020， 6（1）： e000897. doi：10.1136/bmjsem-2020-000897 . |
| [15] | SANDBERG A， B?CK M， CIDER ?， et al. Effectiveness of supervised exercise， home-based exercise， or walk advice strategies on walking performance and muscle endurance in patients with intermittent claudication （SUNFIT trial）： A randomized clinical trial［J］. Eur J Cardiovasc Nurs， 2023， 22（4）： 400-411. doi：10.1093/eurjcn/zvac070 . |
| [16] | MCDERMOTT M M， SPRING B， BERGER J S， et al. Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease： The HONOR randomized clinical trial［J］. JAMA， 2018， 319（16）： 1665-1676. doi：10.1001/jama.2018.3275 . |
| [17] | GARDNER A W， PARKER D E， MONTGOMERY P S， et al. Step-monitored home exercise improves ambulation， vascular function， and inflammation in symptomatic patients with peripheral artery disease： A randomized controlled trial［J］. J Am Heart Assoc， 2014， 3（5）： e001107. doi：10.1161/JAHA.114.001107 . |
| [18] | DJERF H， MILLINGER J， FALKENBERG M， et al. Absence of long-term benefit of revascularization in patients with intermittent claudication： Five-year results from the IRONIC randomized controlled trial［J］. Circ Cardiovasc Interv， 2020， 13（1）： e008450. doi：10.1161/CIRCINTERVENTIONS.119.008450 . |
| [19] | KLAPHAKE S， FAKHRY F， ROUWET E V， et al. Long-term follow-up of a randomized clinical trial comparing endovascular revascularization plus supervised exercise with supervised exercise only for intermittent claudication［J］. Ann Surg， 2022， 276（6）： e1035-e1043. doi：10.1097/SLA.0000000000004712 . |
| [20] | THANIGAIMANI S， PHIE J， SHARMA C， et al. Network meta-analysis comparing the outcomes of treatments for intermittent claudication tested in randomized controlled trials［J］. J Am Heart Assoc， 2021， 10（9）： e019672. doi：10.1161/JAHA.120.019672 . |
| [21] | 池博. Buerger运动联合步行锻炼对下肢动脉硬化闭塞症介入术后患者的影响［D］. 成都： 成都中医药大学， 2019： 88. |
| [22] | 杜亚丽， 吴伟伟， 张杰， 等. 运动训练综合康复对老年下肢动脉硬化闭塞症患者行支架置入术后血管功能及预后的影响［J］. 老年医学与保健， 2022， 28（4）： 747-750. doi：10.3969/j.issn.1008-8296.2022.04.010 . |
| [23] | ANAND S S， BOSCH J， EIKELBOOM J W， et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease： An international， randomised， double-blind， placebo-controlled trial［J］. Lancet， 2018， 391（10117）： 219-229. doi：10.1016/S0140-6736（17）32409-1 . |
| [24] | BONACA M P， BAUERSACHS R M， ANAND S S， et al. Rivaroxaban in peripheral artery disease after revascularization［J］. N Engl J Med， 2020， 382（21）： 1994-2004. doi：10.1056/NEJMoa2000052 . |
| [25] | 中国医师协会心血管内科医师分会. 泛血管疾病抗栓治疗中国专家共识（2024版）［J］. 中华医学杂志， 2024， 104（12）： 906-923. doi：10.3760/cma.j.cn112137-20231101-00959 . |
| [26] | HIATT W R， FOWKES F G R， HEIZER G， et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease［J］. N Engl J Med， 2017， 376（1）： 32-40. doi：10.1056/NEJMoa1611688 . |
| [27] | DUCCI K， LIISTRO F， PORTO I， et al. Ticagrelor versus clopidogrel in patients undergoing implantation of paclitaxel-eluting stent in the femoropopliteal district： A randomized pilot study using frequency-domain optical coherence tomography［J］. Int J Cardiol， 2020， 304： 192-197. doi：10.1016/j.ijcard.2020.01.024 . |
| [28] | BOSE S， DUN C， SOLOMON A J， et al. Editor’s choice–infrapopliteal peripheral vascular interventions for claudication are performed frequently in the USA and are associated with poor long term outcomes［J］. Eur J Vasc Endovasc Surg， 2025， 69（1）： 89-101. doi：10.1016/j.ejvs.2024.06.017 . |
| [29] | KOELEMAY M J W， VAN REIJEN N S， VAN DIEREN S， et al. Editor’s choice–randomised clinical trial of supervised exercise therapy vs. endovascular revascularisation for intermittent claudication caused by iliac artery obstruction： The SUPER study［J］. Eur J Vasc Endovasc Surg， 2022， 63（3）： 421-429. doi：10.1016/j.ejvs.2021.09.042 . |
| [30] | KAYSSI A， AL-ATASSI T， OREOPOULOS G， et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs［J］. Cochrane Database Syst Rev， 2016， 2016（8）： CD011319. doi：10.1002/14651858.CD011319.pub2 . |
| [31] | 祁光伟， 杨艳， 杨柳雨， 等. 3种血管腔内方式治疗下肢动脉硬化闭塞症股腘动脉病变的临床疗效比较［J］. 中国普外基础与临床杂志， 2025， 32（6）： 756-762. |
/
| 〈 |
|
〉 |